PARTNERSHIP:

PLAINSBORO, NJ (PRWEB) – CURE™ magazine, the largest consumer publication in the U.S. focused entirely on cancer, has formed a partnership with Medocity, Inc, to add a lineup of articles, blogs, videos and educational content to Medocity’s iCancerHealth™ platform. Leveraging new, innovative and comprehensive virtual-care technology, iCancerHealth is designed to bridge the gap between the clinic and the home to help patients

• Manage and track their medications, symptoms and treatment plans,
• Receive guidance, recommendations, and timely disease- and drug-specific information, and
• Share and connect with their care team, family and friends.

With the addition of content from CURE, iCancerHealth will now provide journey-based content for patients and their caregivers.

This agreement will improve the lives of cancer patients and their caregivers,” said Mike Hennessy Jr., president of Intellisphere Oncology and Healthcare Specialty Group, MJH.

With iCancerHealth, patients can share detailed records of their daily health, side effects and symptoms with their physicians and nurses in order to help them make more informed clinical decisions. Medocity will customize iCancerHealth with a section devoted exclusively to CURE content.

“This agreement will improve the lives of cancer patients and their caregivers,” said Mike Hennessy Jr., president of Intellisphere Oncology and Healthcare Specialty Group, a part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. “We’ll provide content for the iCancerHealth platform, and we’ll also promote this groundbreaking platform in our magazines and newsletters, and on our website.”

“Medocity is looking forward to providing our users with the helpful information offered by CURE magazine and its related publications,” said Raj Agarwal, CEO and president of Medocity. “The new partnership will further Medocity’s goals of providing better tools to  coordinate care, engage and educate patients, and help avoid unnecessary trips to the emergency room.”

About CURE magazine and CURE Media Group

CURE Media Group’s flagship product, CURE magazine, is the indispensable guide to every stage of the cancer experience. With nearly 1 million readers, CURE is the largest consumer publication in the United States focused entirely on cancer, with broad distribution to cancer patients, cancer centers and advocacy groups. Through the magazine, live meetings, a resource guide for the newly diagnosed, the Extraordinary Healer™ national nursing award, and other books and online tools, CURE Media Group combines science and humanity to make cancer understandable. CURE Media Group is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses, which includes the acclaimed OncLive^®(www.onclive.com) platform of resources for the practicing oncologist. For more information, visit www.curetoday.com or www.mjhassoc.com.

About Medocity

Medocity, headquartered in Parsippany, New Jersey, is a recognized leader in comprehensive virtual care products and services including chronic condition management, televisits, and remote patient monitoring. Our unique, innovative technology combines multiple telehealth capabilities onto a single, integrated care coordination and management platform, along with robust clinical intelligence including rules-based algorithms, alerts and decision support tools to help drive earlier detection and proactive interventions.

The Medocity platform is specifically designed to enable and improve patient-centered care delivered outside the hospital setting, particularly for patients at home who have chronic conditions responsible for more than 80% of the nation’s annual healthcare spend. By promoting patient-clinician engagement through shared connectivity and virtual technology, we enable rich, real-time interactions between patients, clinicians, care professionals and support teams.

Our vision is to dramatically improve care at lower cost for patients when they need it the most – when they’re at home, on their own, or in between visits with their care providers. Virtually. (http://www.medocity.com)